Figure 1.
![Figure 1. Time on study. Swim lane plot of time on study for the 25 patients who achieved an objective response (≥ PR). Y-axis indicates refractoriness (naive [Naï], relapsed [Rel], or refractory [Ref]) of the patient’s myeloma to a PI (bortezomib, carfilzomib, or ixazomib). Arrows indicate patient is still on study. × indicates that patient is off study due to PD, adverse event (WC-AE), death, travel issues, or decreased quality of life (WC-QoL).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/132/24/10.1182_blood-2018-06-858852/6/blood858852f1.png?Expires=1727815701&Signature=Y0AwbefdYRL9fwWcv-cw8sm9n05qlU1Q18x6jwdPoAhHfpEpqNig6q8Mlv6EQq8EMv3ZKX8SSgZDL5jvWAaqAp1bjIOnmBiX7edMpM5DsX5IQDGy14-sWQmE96Z1zk5GpKLsEobtXQ0GuH5jTx4s~DPhuUcPkgsKEz84pcKp~VDADryCdGb5PwYkyKjvjZP5I5fZvlcnvx~Kpk7q01pZUkxlkDaUnmL8PQWdBqI1wAkDrSg3ttWkMHEQZHMA8q~En5icdiCfyhaixmtFpt6JTguapduEMtMZTJrIHpfiTwOOW-v6HcT7Xh1-JJ3d1HJtjJRxK-l~ouhodK3w7NuWBg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Time on study. Swim lane plot of time on study for the 25 patients who achieved an objective response (≥ PR). Y-axis indicates refractoriness (naive [Naï], relapsed [Rel], or refractory [Ref]) of the patient’s myeloma to a PI (bortezomib, carfilzomib, or ixazomib). Arrows indicate patient is still on study. × indicates that patient is off study due to PD, adverse event (WC-AE), death, travel issues, or decreased quality of life (WC-QoL).